Find your next paid study

National Heart, Lung, and Blood Institute (NHLBI)NCT05012111

~$10 – $675

Actual pay is set by the research site.

Chimeric Antigen Receptor T-cell TherapyHematologic Malignancy

Improving Patient Outcomes Through a Digital Health Delivered Intervention to Monitor and Manage Symptoms After Chimeric Antigen Receptor T-Cell Therapy

The goal of this study is to refine and test a digital intervention named WAYPOINT to help patients monitor and manage symptoms after CAR-T therapy. The main q…

Massachusetts General HospitalNCT07886190

Actual pay is set by the research site.

Phase 3

A Two-Part, Randomized, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Mibavademab in Patients With Generalized Lipodystrophy (LAGO)

This study is researching a new drug called mibavademab (called "study drug"). The study involves participants with a condition called Generalized Lipodystroph…

Generalized Lipodystrophy

Regeneron PharmaceuticalsNCT07220785

~$50 – $2,100

Actual pay is set by the research site.

SCHIZOPHRENIA 1 (Disorder)Schizo Affective DisorderHealthy Adult

Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium

In Study 2, investigators will recruit individuals with schizophrenia (SZ) and or schizoaffective disorder (SZA) and healthy controls (HC) using optimized beha…

Washington University School of MedicineNCT07875790

Actual pay is set by the research site.

BREATHE: An Efficacy-implementation Trial of a Brief Shared Decision Making Intervention Among Black Adults With Uncontrolled Asthma in Federally Qualified Health Centers (Trial and Post-trial)

This study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qu…

Asthma

Columbia UniversityNCT05341726

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Open-label, Study Assessing the Safety, Tolerability and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDC…

Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Metastatic Non-Small Cell Lung Cancer (NSCLC)

Bristol-Myers SquibbNCT07680764

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

Sensory Evaluation of Cigarettes Claiming Removal of Menthol as a Characterizing Flavor

This clinical trial tests how well current daily smoking adults can identify flavors of cigarettes. Menthol cigarettes account for 31 percent of cigarettes sol…

Cigarette Smoking-Related Carcinoma

Roswell Park Cancer InstituteNCT06816459

~$500 – $11,250

Actual pay is set by the research site.

Phase 2

A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII

The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) b…

Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more

Black Diamond Therapeutics, Inc.NCT07326566

~$75 – $2,800

Actual pay is set by the research site.

Phase 4

Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents

A considerable hurdle to the development of novel, more effective therapies for diabetic retinal disease is the limited number of primary endpoints available f…

Diabetic Retinal Disease

Jaeb Center for Health ResearchNCT07567833

~$25 – $1,500

Actual pay is set by the research site.

The Systemic Nature of Severe Traumatic Brain Injury: Multi-Omic Analysis of Neural Trauma, Autoantibodies and the Gut-Brain Axis: The MANTRA Study

Severe traumatic brain injury (sTBI) is a devastating condition with no targeted therapies available to prevent secondary injury. Previous studies have demonst…

Severe Traumatic Brain Injury

Corewell Health WestNCT07679126

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04).

Researchers are looking for other ways to treat breast cancer (BC) that is hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+…

Breast Neoplasms

Merck Sharp & Dohme LLCNCT07060807

~$50 – $2,100

Actual pay is set by the research site.

Solid TumorSolid Tumor, Adult

DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep): A Trial Assessing Feasibility and Acceptability of an Intervention for Depressed Mood, Insomnia, and Fatigue Symptoms in Latino Cancer Patients

The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depressi…